AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] BellRing Brands, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Houlihan Lokey, Inc. filed a Form 144 indicating a proposed sale of 200 common shares through Morgan Stanley Smith Barney on 14 July 2025. The aggregate market value of the shares to be sold is $37,918, versus 53,789,857 shares outstanding, representing a negligible 0.0004% of total shares.

The filer previously executed two Rule 10b5-1 sales for the same accountâ€�200 shares on 13 June 2025 for $34,874 and 200 shares on 13 May 2025 for $35,692. The securities being sold were acquired as restricted stock on 26 May 2021. No material adverse information was acknowledged by the seller, as required under Rule 144 representations.

This notice reflects routine insider share disposition activity. The transaction size is immaterial relative to market capitalization and does not appear to signal a strategic change or financial stress for HLI.

Houlihan Lokey, Inc. ha presentato un Modulo 144 indicando una proposta di vendita di 200 azioni ordinarie tramite Morgan Stanley Smith Barney il 14 luglio 2025. Il valore di mercato complessivo delle azioni da vendere è di 37.918 $, rispetto a 53.789.857 azioni in circolazione, rappresentando una percentuale trascurabile dello 0,0004% del totale delle azioni.

Il soggetto che ha effettuato la segnalazione aveva già eseguito due vendite ai sensi della Regola 10b5-1 per lo stesso conto�200 azioni il 13 giugno 2025 per 34.874 $ e 200 azioni il 13 maggio 2025 per 35.692 $. I titoli venduti erano stati acquisiti come azioni ristrette il 26 maggio 2021. Il venditore non ha riconosciuto alcuna informazione negativa rilevante, come richiesto dalle dichiarazioni della Regola 144.

Questa comunicazione riflette un'attività di normale cessione di azioni da parte di un insider. La dimensione della transazione è irrilevante rispetto alla capitalizzazione di mercato e non sembra indicare un cambiamento strategico o tensioni finanziarie per HLI.

Houlihan Lokey, Inc. presentó un Formulario 144 indicando una propuesta de venta de 200 acciones comunes a través de Morgan Stanley Smith Barney el 14 de julio de 2025. El valor de mercado agregado de las acciones a vender es de $37,918, frente a 53,789,857 acciones en circulación, representando un porcentaje insignificante del 0.0004% del total de acciones.

El declarante previamente realizó dos ventas bajo la Regla 10b5-1 para la misma cuenta�200 acciones el 13 de junio de 2025 por $34,874 y 200 acciones el 13 de mayo de 2025 por $35,692. Los valores vendidos fueron adquiridos como acciones restringidas el 26 de mayo de 2021. El vendedor no reconoció información adversa material, según lo requerido por las declaraciones de la Regla 144.

Este aviso refleja una actividad de disposición rutinaria de acciones por parte de un insider. El tamaño de la transacción es insignificante en relación con la capitalización de mercado y no parece señalar un cambio estratégico o problemas financieros para HLI.

Houlihan Lokey, Inc.ëŠ� 2025ë…� 7ì›� 14ì� Morgan Stanley Smith Barneyë¥� 통해 200ì£� 보통ì£� 매ê°ì� 제안하는 Form 144ë¥� 제출했습니다. ë§¤ë„ ì˜ˆì • 주ì‹ì� ì´� 시장 가치는 $37,918ì´ë©°, ì´� 발행 ì£¼ì‹ ìˆ� 53,789,857ì£� 대ë¹� 미미í•� 0.0004%ì—� 해당합니ë‹�.

ì‹ ê³ ìžëŠ” ë™ì¼ 계좌ì—� 대í•� ì´ì „ì—� ë‘� 차례 Rule 10b5-1 매ë„ë¥� 실행했으며â€�2025ë…� 6ì›� 13ì� 200ì£�, $34,874 ë°� 2025ë…� 5ì›� 13ì� 200ì£�, $35,692 매ë„했습니다. 매ë„ë� ì¦ê¶Œì€ 2021ë…� 5ì›� 26ì� 제한 주ì‹ìœ¼ë¡œ ì·¨ë“ë� 것입니다. íŒë§¤ìžëŠ” Rule 144 진술ì—� ë”°ë¼ ì¤‘ëŒ€í•� ë¶€ì •ì  ì •ë³´ë¥� ì¸ì •하지 않았습니ë‹�.

ì´ë²ˆ 공지ëŠ� ì¼ìƒì ì¸ ë‚´ë¶€ìž� ì£¼ì‹ ì²˜ë¶„ 활ë™ì� ë°˜ì˜í•©ë‹ˆë‹�. 거래 규모ëŠ� 시가ì´ì•¡ 대ë¹� 미미하며, HLIì—� 대í•� ì „ëžµì � 변화나 재정ì � 어려움ì� 시사하지 않습니다.

Houlihan Lokey, Inc. a déposé un Formulaire 144 indiquant une proposition de vente de 200 actions ordinaires via Morgan Stanley Smith Barney le 14 juillet 2025. La valeur marchande globale des actions à vendre s'élève à 37 918 $, sur un total de 53 789 857 actions en circulation, représentant une part négligeable de 0,0004% du total des actions.

Le déclarant avait précédemment réalisé deux ventes selon la règle 10b5-1 pour le même compte�200 actions le 13 juin 2025 pour 34 874 $ et 200 actions le 13 mai 2025 pour 35 692 $. Les titres vendus avaient été acquis en tant qu'actions restreintes le 26 mai 2021. Aucun renseignement défavorable significatif n'a été reconnu par le vendeur, conformément aux déclarations requises par la règle 144.

Cette notification reflète une activité de cession d'actions d'initié de routine. La taille de la transaction est insignifiante par rapport à la capitalisation boursière et ne semble pas indiquer un changement stratégique ou des difficultés financières pour HLI.

Houlihan Lokey, Inc. reichte ein Formular 144 ein, in dem ein geplanter Verkauf von 200 Stammaktien über Morgan Stanley Smith Barney am 14. Juli 2025 angegeben wurde. Der aggregierte Marktwert der zu verkaufenden Aktien beträgt 37.918 $, bei insgesamt 53.789.857 ausstehenden Aktien, was einen vernachlässigbaren Anteil von 0,0004% der Gesamtaktien darstellt.

Der Meldende hatte zuvor zwei Verkäufe gemäß Regel 10b5-1 für dasselbe Konto durchgeführt�200 Aktien am 13. Juni 2025 für 34.874 $ und 200 Aktien am 13. Mai 2025 für 35.692 $. Die verkauften Wertpapiere wurden als Restricted Stock am 26. Mai 2021 erworben. Kein wesentlicher negativer Umstand wurde vom Verkäufer gemäß den Angaben der Regel 144 anerkannt.

Diese Mitteilung spiegelt eine übliche Insider-Aktienveräußerung wider. Die Transaktionsgröße ist im Verhältnis zur Marktkapitalisierung unerheblich und deutet nicht auf eine strategische Änderung oder finanzielle Schwierigkeiten bei HLI hin.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine Form 144 for 200 shares; immaterial insider sale—neutral impact.

The filing discloses a proposed sale of 200 HLI shares (~$38k) plus history of two similar 200-share trades over the past three months. With 53.8 million shares outstanding, the cumulative 600-share disposition equals roughly 0.001% of equity, far below thresholds that generally alter insider-sentiment assessments. No information suggests unusual timing or undisclosed negative developments; the shares were originally granted as restricted stock in 2021. Overall, the event is non-material and should not affect valuation or liquidity.

Houlihan Lokey, Inc. ha presentato un Modulo 144 indicando una proposta di vendita di 200 azioni ordinarie tramite Morgan Stanley Smith Barney il 14 luglio 2025. Il valore di mercato complessivo delle azioni da vendere è di 37.918 $, rispetto a 53.789.857 azioni in circolazione, rappresentando una percentuale trascurabile dello 0,0004% del totale delle azioni.

Il soggetto che ha effettuato la segnalazione aveva già eseguito due vendite ai sensi della Regola 10b5-1 per lo stesso conto�200 azioni il 13 giugno 2025 per 34.874 $ e 200 azioni il 13 maggio 2025 per 35.692 $. I titoli venduti erano stati acquisiti come azioni ristrette il 26 maggio 2021. Il venditore non ha riconosciuto alcuna informazione negativa rilevante, come richiesto dalle dichiarazioni della Regola 144.

Questa comunicazione riflette un'attività di normale cessione di azioni da parte di un insider. La dimensione della transazione è irrilevante rispetto alla capitalizzazione di mercato e non sembra indicare un cambiamento strategico o tensioni finanziarie per HLI.

Houlihan Lokey, Inc. presentó un Formulario 144 indicando una propuesta de venta de 200 acciones comunes a través de Morgan Stanley Smith Barney el 14 de julio de 2025. El valor de mercado agregado de las acciones a vender es de $37,918, frente a 53,789,857 acciones en circulación, representando un porcentaje insignificante del 0.0004% del total de acciones.

El declarante previamente realizó dos ventas bajo la Regla 10b5-1 para la misma cuenta�200 acciones el 13 de junio de 2025 por $34,874 y 200 acciones el 13 de mayo de 2025 por $35,692. Los valores vendidos fueron adquiridos como acciones restringidas el 26 de mayo de 2021. El vendedor no reconoció información adversa material, según lo requerido por las declaraciones de la Regla 144.

Este aviso refleja una actividad de disposición rutinaria de acciones por parte de un insider. El tamaño de la transacción es insignificante en relación con la capitalización de mercado y no parece señalar un cambio estratégico o problemas financieros para HLI.

Houlihan Lokey, Inc.ëŠ� 2025ë…� 7ì›� 14ì� Morgan Stanley Smith Barneyë¥� 통해 200ì£� 보통ì£� 매ê°ì� 제안하는 Form 144ë¥� 제출했습니다. ë§¤ë„ ì˜ˆì • 주ì‹ì� ì´� 시장 가치는 $37,918ì´ë©°, ì´� 발행 ì£¼ì‹ ìˆ� 53,789,857ì£� 대ë¹� 미미í•� 0.0004%ì—� 해당합니ë‹�.

ì‹ ê³ ìžëŠ” ë™ì¼ 계좌ì—� 대í•� ì´ì „ì—� ë‘� 차례 Rule 10b5-1 매ë„ë¥� 실행했으며â€�2025ë…� 6ì›� 13ì� 200ì£�, $34,874 ë°� 2025ë…� 5ì›� 13ì� 200ì£�, $35,692 매ë„했습니다. 매ë„ë� ì¦ê¶Œì€ 2021ë…� 5ì›� 26ì� 제한 주ì‹ìœ¼ë¡œ ì·¨ë“ë� 것입니다. íŒë§¤ìžëŠ” Rule 144 진술ì—� ë”°ë¼ ì¤‘ëŒ€í•� ë¶€ì •ì  ì •ë³´ë¥� ì¸ì •하지 않았습니ë‹�.

ì´ë²ˆ 공지ëŠ� ì¼ìƒì ì¸ ë‚´ë¶€ìž� ì£¼ì‹ ì²˜ë¶„ 활ë™ì� ë°˜ì˜í•©ë‹ˆë‹�. 거래 규모ëŠ� 시가ì´ì•¡ 대ë¹� 미미하며, HLIì—� 대í•� ì „ëžµì � 변화나 재정ì � 어려움ì� 시사하지 않습니다.

Houlihan Lokey, Inc. a déposé un Formulaire 144 indiquant une proposition de vente de 200 actions ordinaires via Morgan Stanley Smith Barney le 14 juillet 2025. La valeur marchande globale des actions à vendre s'élève à 37 918 $, sur un total de 53 789 857 actions en circulation, représentant une part négligeable de 0,0004% du total des actions.

Le déclarant avait précédemment réalisé deux ventes selon la règle 10b5-1 pour le même compte�200 actions le 13 juin 2025 pour 34 874 $ et 200 actions le 13 mai 2025 pour 35 692 $. Les titres vendus avaient été acquis en tant qu'actions restreintes le 26 mai 2021. Aucun renseignement défavorable significatif n'a été reconnu par le vendeur, conformément aux déclarations requises par la règle 144.

Cette notification reflète une activité de cession d'actions d'initié de routine. La taille de la transaction est insignifiante par rapport à la capitalisation boursière et ne semble pas indiquer un changement stratégique ou des difficultés financières pour HLI.

Houlihan Lokey, Inc. reichte ein Formular 144 ein, in dem ein geplanter Verkauf von 200 Stammaktien über Morgan Stanley Smith Barney am 14. Juli 2025 angegeben wurde. Der aggregierte Marktwert der zu verkaufenden Aktien beträgt 37.918 $, bei insgesamt 53.789.857 ausstehenden Aktien, was einen vernachlässigbaren Anteil von 0,0004% der Gesamtaktien darstellt.

Der Meldende hatte zuvor zwei Verkäufe gemäß Regel 10b5-1 für dasselbe Konto durchgeführt�200 Aktien am 13. Juni 2025 für 34.874 $ und 200 Aktien am 13. Mai 2025 für 35.692 $. Die verkauften Wertpapiere wurden als Restricted Stock am 26. Mai 2021 erworben. Kein wesentlicher negativer Umstand wurde vom Verkäufer gemäß den Angaben der Regel 144 anerkannt.

Diese Mitteilung spiegelt eine übliche Insider-Aktienveräußerung wider. Die Transaktionsgröße ist im Verhältnis zur Marktkapitalisierung unerheblich und deutet nicht auf eine strategische Änderung oder finanzielle Schwierigkeiten bei HLI hin.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DAVENPORT DARCY HORN

(Last) (First) (Middle)
C/O BELLRING BRANDS, INC.
2503 S. HANLEY ROAD

(Street)
ST. LOUIS MO 63144

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BELLRING BRANDS, INC. [ BRBR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
PRES. AND CEO
3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/11/2025 S(1) 1,600 D $57.66(2) 198,778 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2025.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.32 to $58.00 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ Craig L. Rosenthal, Attorney in Fact 07/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Bellring Brands Inc

NYSE:BRBR

BRBR Rankings

BRBR Latest News

BRBR Latest SEC Filings

BRBR Stock Data

6.87B
125.37M
1.32%
100.98%
3.61%
Packaged Foods
Food and Kindred Products
United States
ST. LOUIS